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	 A	series	of	2‐pyrazolines	(3a‐d)	were	obtained	by	reaction	1,3‐dipolar	cycloadditions	of	α,β‐
unsaturated	 cyclohexanone	 derivatives	 (2a‐c)	 with	 hydrazine	 hydrate	 and	 4‐
nitrophenylhydrazine	in	the	presence	of	acetic	acid	and	ethanol	as	solvents.	The	structures	of
the	synthesized	compounds	were	confirmed	by	spectroscopic	methods;	IR,	1H	and	13C	NMR.	
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1.	Introduction	
	
Pyrazoline	 belongs	 to	 a	 class	 of	 five‐membered	 ring	
compounds	having	two	nitrogen	atoms	located	adjacent	to	each	
other	 [1].	 Several	 pyrazoline	 derivatives	 possess	 important	
biological	 activities	 such	 as	 anti‐inflammatory	 [2‐4],	
antidepressant	 [5‐6],	 antipyretic	 [7],	 antibacterial	 [8‐13],	
antifungal	 [8,11,14]	 and	 antitumoral	 [15].	 Over	 the	 years,	 the	
structure	 of	 pyrazoline	 [1,16]	 has	 received	 considerable	
attention.	 Of	 particular	 interest	 is	 the	 use	 of	 pyrazolines	 as	
synthetic	 intermediates	 for	 preparing	 cyclopropane	 [17‐19]	
and	pyrazole	[1,20‐23]	derivatives.	Moreover	pyrazolines	have	
played	 a	 crucial	 role	 in	 the	 development	 of	 theory	 in	
heterocyclic	chemistry	and	also	are	extensively	useful	synthons	
in	organic	chemistry	[1].		
1,3‐Dipolar	 cycloadditions	 is	 a	 general	 methodology	 that	
has	 been	 applied	 both	 to	 the	 synthesis	 of	 five‐membered	
heterocyclic	 compounds	 such	 as	 2‐pyrazolines	 using	 α,β‐
unsaturated	ketones	as	starting	materials	[1].		
The	 α,β‐unsaturated	 ketones	 have	 been	 attracting	 much	
more	attention,	particularly	the	α,β‐unsaturated	derivatives	of	
cyclohexanone,	 not	 only	 due	 to	 their	 intriguing	 biological	
activities	 such	 as	 antiangiogenic	 [24,25],	 cytotoxicity	 [26,27],	
cholesterol‐lowering	 activity	 [28],	 use	 in	 agrochemicals,	
pharmaceuticals	 and	 perfumes	 [29],	 and	 as	 liquid	 crystalline	
polymer	 units	 [30],	 but	 also	 as	 important	 precursors	 for	 the	
synthesis	 of	 heterocyclic	 compounds	 such	 as	 pyrazolines.	
Generally,	 these	 compounds	 are	 prepared	 by	 Claisen‐Schmidt	
condensation	from	aromatic	aldehydes	and	ketons	[31‐39].	
In	 this	 study,	 we	 have	 synthesized	 a	 series	 of	 pyrazoline	
derivatives	 3a‐d	 using	 α,β‐unsaturated	 cyclohexanone	
derivatives	2a‐c	 as	 starting	 materials	 (Scheme	 1	 and	 2).	 The	
structures	of	the	newly	synthesized	compounds	2c,	3a	and	3d	
were	 confirmed	 by	 IR	 and	 their	 spectroscopic	 analyses.	
Compounds	3b	 and	3c,	were	 synthesized	 by	 Kok	 et.	 al.	 [40],	
using	 another	 method	 which	 was	 reported	 in	 the	 cited	
reference.	We	report	also	in	this	paper,	reaction	of	the	new	α,β‐
unsaturated	 ketone	 2c	with	 hydrazine	 hydrate	 in	 hot	 acetic	
acid,	 this	 reaction	 produced	 complex	 mixture	 of	 unidentified	
products.	 Bioactivities	 studies	 of	 all	 synthesized	 compounds	
will	be	the	subject	of	future	publication.		
	
2.	Experimental	
	
2.1.	Instrumentation	
	
Melting	 points	 were	 determined	 with	 a	 (Bransted/	
‐Electrothermal)	 apparatus	 and	 are	 uncorrected.	 IR	 spectra	
were	recorded	in	KBr	pellets	on	(a	Perkin‐Elmer	FT‐IR‐01	and	
a	 Shimadzu	 FT‐IR‐8400S)	 spectrophotometers.	 Nuclear	
magnetic	 resonance	 (NMR)	 spectra	 were	 recorded	 using	
Bruker	 Advance	 DRX	 400	 spectrometer	 (400.13	 MHz	 for	 1H	
NMR	 and	100.62	MHz	 for	 13C	NMR)	 and	Bruker	Advance	 250	
spectrometer	(250.13	MHz	for	1H	NMR	and	62.89	MHz	for	13C	
NMR).	 Chemical	 shift	 values	 are	 reported	 in	 ppm	 relative	 to	
TMS	as	internal	reference	in	CDCl3.		
	
2.2.	Synthesis	
	
2.2.1.	Synthesis	of	α,β‐unsaturated	derivatives	of	
cyclohexanone	
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Scheme	1
	
	
A	mixture	 of	 the	 aromatic	 aldehyde	 (20	mmol,	 2	 eq.)	 and	
cyclohexanone	 (10	 mmol,	 1	 eq.)	 were	 dissolved	 in	 15	 mL	 of	
ethanol	 in	 a	 simple	 necked	 round	 bottomed	 flask	 and	 stirred	
for	several	minutes	at	0	°C	(ice	bath).	Into	this	solution,	10	mL	
of	 a	 40%	NaOH	 solution	 in	water	was	 then	 added	 drop	wise	
over	 several	 minutes.	 The	 mixture	 is	 then	 allowed	 to	 stir	 at	
room	 temperature	 for	 approximately	 4	 h.	 The	 yellow	 solid	
obtained	was	 filtered	 and	washed	with	 cold	water	 and	 dried.	
The	product,	so‐obtained,	was	crystallized	with	ethanol	to	give	
the	desired	compounds	in	good	yields	(Scheme	1).	
2,6‐Dibenzylidenecyclohexanone	 (2a):	 Color:	 Yellow	
crystals.	Yield:	90%	yield.	M.p.:	118‐119	°C	 (117‐118	°C	[41]).	
1H	NMR	 (400.13	MHz,	CDCl3,	 δ,	 ppm):	1.66‐1.83	 (m,	2H,	CH2),	
2.89‐2.95	(m,	4H,	2	CH2),	7.24‐7.48	(m,	10H,	Ar‐H),	7.80	(s,	2H,	
2	CH=C).	13C	NMR	(100.6	MHz,	CDCl3,	δ,	ppm):	22.8	(CH2),	28.3	
(2	CH2),	128.2	(4	CH	of	Ar‐H),	128.4	(2	Ar‐H),	130.2	(4	CH	of	Ar‐
H),	135.8	(2	CH),	135.9	(2	C‐Ar),	136.7	(2	C=C),	190.0	(C=O).		
2,6‐Bis(4‐fluorobenzylidene)cyclohexanone	 (2b):	 Color:	
Yellow	crystals.	Yield:	86%.	M.p.:	155‐156	°C	(156‐158	°C	[37]).	
1H	NMR	 (400.13	MHz,	CDCl3,	 δ,	 ppm):	2.75‐1.82	 (m,	2H,	CH2),	
2.86‐2.89	(m,	4H,	2	CH2),	7.05‐7.11	(m,	4H,	Ar‐H),	7.42‐7.46	(m,	
4H,	Ar‐H),	7.74	(s,	2H,	2	CH=C).	13C	NMR	(100.6	MHz,	CDCl3,	δ,	
ppm):	22.9	(CH2),	28.3	(2	CH2),	115.5	(d,	J	=	22.1	Hz,	4	CH	of	Ar‐
H),	132.0	(d,	J	=	4.0	Hz,	2	Ar‐C),	132.3	(d,	J	=	9.0	Hz,	4	CH	of	Ar‐
H),	135.7	(d,	J	=	2.0	Hz,	2	CH),	135.8	(2	C=C),	189.9	(C=O).	
2,6‐Bis(4‐(methylthio)benzylidene)cyclohexanone	 (2c).	
Color:	Yellow	powder.	Yield:	87%.	M.p.:	184‐185	°C.	IR	(KBr,	ν,	
cm‐1):	 2922	 (C‐H),	 1658	 (C=O),	 1599	 (C=C).	 1H	 NMR	 (400.13	
MHz,	CD2Cl2,	δ,	ppm):	1.77‐1.83	(m,	2H,	CH2),	2.51	(s,	6H,	2	S‐
CH3),	 2.91‐2.94	 (m,	 4H,	 2	 CH2),	 7.27	 (d,	 J	 =	 8.0	Hz,	 4H,	 Ar	H),	
7.43	 (d,	 J	 =	8.0	Hz,	4	H,	 Ar	H),	 7.69	 (s,	 2H,	2	CH=C).	 13C	NMR	
(100.6	MHz,	 CDCl3,	 δ,	 ppm):	 14.6	 (2	 CH3),	 22.5	 (CH2),	 28.1	 (2	
CH2),	125.1	(4	CH	of	Ar	H),	130.4	(4	CH	of	Ar‐H),	132.1	(2	Ar‐C),	
135.3	(2	CH),	135.4	(2	C=C),	139.6	(2	Ar‐C),	189.0	(C=O).		
	
2.2.2.	Synthesis	of	pyrazolines	
	
Compound	 2a	 (3	 mmol)	 was	 treated	 with	 4‐
nitrophenylhydrazine	 (3	 mmol)	 in	 ethanol	 (15	 mL).	 The	
mixture	 was	 refluxed	 for	 12	 h.	 A	 precipitation	 of	 a	 yellow	
powder	3a	 was	 separated	 by	 filtration,	 and	 crystallized	 from	
ethanol.	Compounds	3b	and	3d	were	prepared	from	compound	
2b	and	2c	(1.5	mmol),	respectively,	and	hydrazine	hydrate	(1.5	
mmol)	 in	ethanol	(12	mL)	using	the	same	procedure	given	for	
compound	 3a.	 The	 products	 3b	 and	 3d	 were	 obtained	 as	
yellow	and	white	 crystals	 respectively.	 Pyrazoline	3c,	a	white	
powder,	 was	 prepared	 from	 compound	 2b	 (3	 mmol)	 and	
hydrazine	 hydrate	 (3	mmol)	 using	 the	 same	 procedure	 given	
for	compound	3a	but	with	acid	acetic	as	solvent	(Scheme	2).	
7‐Benzylidene‐2‐(4‐nitrophenyl)‐3‐phenyl‐3,3a,4,5,6,7‐hexa	
hydro‐2H‐indazole	(3a):	Color:	Yellow	crystals.	Yield:	92%.	M.p.:	
182	°C.	IR	(KBr,	ν,	cm‐1):	2949	(C‐H),	1595	(C=N),	1500	(C=C),	
1560	 (N‐O),	 1382	 (N‐O),	 1045	 (C‐N).	 1H	 NMR	 (250.13	 MHz,	
CDCl3,	δ,	ppm):	1.45‐1.55	(m,	1H,	C‐H),	1.72‐1.77	(m,	1H,	C‐H),	
1.95‐2.00	 (m,	 1H,	 C‐H),	 2.25	 (m,	 1H,	 C‐H),	 2.45	 (m,	 1H,	 C‐H),	
3.05‐3.10	(m,	2H,CH),	4.75	(d,	J	=	10.5	Hz,	1H,	N‐CH),	7.01	(d,	J	=	
9.25	Hz,	 2H,	 ArH),	 7.30‐7.41	 (m,	 11H,	 Ar	 +	 =CH).	 8.02	 (d,	 J	 =	
9.25	 Hz,	 2H,	 ArH).	 13C	 NMR	 (62.9	 MHz,	 CDCl3,	 δ,	 ppm):	 24.2	
(CH2),	28.9	(CH2),	29.6	(CH2),	57.9	(CH),	72.2	(CH),	113.1	(2	CH	
of	Ar‐H),	125.4	(2	CH	of	Ar‐H),	125.6	(2	CH	of	Ar‐H),	127.4	(CH	
of	Ar‐H),	127.9	(CH	of	Ar‐H	),	128.0	(CH=C),	128.3	(2	CH	of	Ar‐
H),	 129.5	 (2	 CH	 of	 Ar‐H),	 129.6	 (2	 CH	 of	 Ar‐H),	 130.1	 (Ar‐C),	
136.2	 (C=C),	 139.5	 (Ar‐C),	 140.8	 (Ar‐C),	 150.3	 (Ar‐C),	 156.6	
(C=N).		
7‐(4‐Fluorobenzylidene)‐3‐(4‐fluorophenyl)‐3,3a,4,5,6,7‐	
hexahydro‐2H‐	 indazole	 [40]	 (3b):	Color:	 Pale	 yellow	 powder.	
Yield:	 70%.	M.p.:	 179‐181	 °C.	 1H	NMR	 (400.13	MHz,	 CDCl3,	 δ,	
ppm):	1.36‐1.58	(m,	2H,	CH),	1.91‐2.06	 (m,	2H,	CH),	2.40‐2.33	
(m,	 1H,	 CH),	 2.70‐2.98	 (m,	 2H,	 CH),	 4.48	 (d,	 J=	 12.0	 Hz,	 CH),	
7.01‐7.47	(m,	10H,	8	Ar‐H+	CH=C	+	N‐H).	
1‐(7‐(4‐fluorobenzylidene)‐3‐(4‐fluorophenyl)‐3,3a,4,5,6,7‐
hexahydro‐2H‐indazol‐2‐yl)	 ethanone	 [40]	 (3c):	 Color:	 White	
powder.	Yield:	91%.	1H	NMR	(400.13	MHz,	CDCl3,	δ,	ppm):	1.48‐
1.51	(m,	1H,	CH),	1.68‐1.72	(m,	1H,	CH),	1.94‐2.20	(m,	2H,	CH),	
2.38	 (s,	 3H,	 CH3),	 2.38‐2.43	 (m,	 1H,	 CH),	 2.95‐3.04	 (m,	 2H,	 2	
CH),	 4.92	 (d,	 J=	 8.0	 Hz,	 1H,	 CH),	 7.03‐7.36	 (m,	 9H,	 8	 Ar‐H	 +	
CH=C).	
7‐(4‐(Methylthio)benzylidene)‐3‐(4‐(methylthio)phenyl)‐3,	
3a,4,5,6,7‐hexahydro‐2H‐indazole	 (3d):	 Color:	 White	 crystals.	
Yield:	85%.	M.p.:	150	°C.	1H	NMR	(400.13	MHz,	CDCl3,	δ,	ppm	):	
1.47‐1.54	(m,	2H,	C‐H),	1.93‐2.06	(m,	2H,	C‐H),	2.43	(m,	1H,	C‐
H),	2.52	(s,	6H,	2	S‐CH3),	2.79	(m,	1H,	C‐H),	3.02	(m,	1H,	C‐H),	
4.48	(d,	J	=	8.0	Hz,	1H,	N‐CH),	5.95	(s,	1H,	CH=C),	7.18	(s,	1H,	N‐
H)	7.24	‐7.44	(m,	8H,	ArH).	13C	NMR	(100.6	MHz,	CDCl3,	δ,	ppm	
):	15.6	(S‐CH3),	15.9	(S‐CH3),	24.4	(CH2),	28.4	(CH2),	28.6	(CH2),	
53.7	(CH),	72.8	(CH),	126.0	(2	CH	of	Ar‐H),	126.8	(2	CH	of	Ar‐H),	
127.6	 (2	CH	of	Ar‐H),	127.7	 (Ar‐C),130.1	(2	CH	of	Ar‐H),	130.6	
(CH=C),	 133.5	 (C=C),	137.2	 (Ar‐C),	 137.5	 (Ar‐C),	 137.8	 (Ar‐C),	
156.7	(C=N).	
	
3.	Results	and	discussion	
	
The	 α,β‐unsaturated	 cyclohexanone	 derivatives,	 2a‐c,	
(Scheme	 1)	were	 obtained	 by	 condensation	 of	 cyclohexanone	
with	substituted	benzaldehydes,	1a‐c,	with	excellent	yields	due	
to	 the	 stability	 of	 α,β‐unsaturated	 cyclohexanone	 derivatives	
[41].	 Compounds	 2a	 [42]	 and	 2b	 [37]	 were	 identified	 by	
comparing	 their	 1H	 and13C	 NMR	 spectral	 data	 with	 those	
reported	in	the	cited	references.	But	the	new	compound	2c	was	
elucidated	by	 IR,	 1H	NMR	and	 13C	NMR.	 In	 the	 IR	 spectrum,	 a	
strong	 band	 around	 1658	 cm‐1	 indicates	 the	 presence	 of	
conjugated	carbonyl	and	a	band	at	1599	cm‐1	for	(C=C)	group.	
In	the	1H	NMR	spectra,	the	olefinic	protons	gave	a	singlet	signal	
at	(7.69	ppm).	 13C	NMR	chemical	shifts	of	 the	C=O	group	have	
been	assigned	at	 (189.0	ppm).	Pyrazoline	3a	was	 synthesized	
by	 reaction	 of	 compound	 2a	with	 4‐nitrophenylhydrazine	 in	
the	presence	of	glacial	acetic	acid	in	low	yield	(34%).	When	the	
reaction	was	 repeated	 using	 ethanol	 as	 solvent	 rather	 glacial	
acetic	 acid,	 compound	 3a	 was	 obtained	 in	 high	 yield	 (92%)	
(Scheme	2).	Pyrazolines	3b	and	3d	were	obtained	by	reaction	
of	 compounds	2b	 and	2c	 respectively	with	hydrazine	hydrate	
in	 ethanol	 using	 the	 same	 procedure	 given	 for	 compound	3a	
[43].		
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Scheme	2
	
	
Compound	2b	was	allowed	to	react	with	hydrazine	hydrate	
in	hot	acetic	acid	 to	afford	pyrazoline	derivative	3c	with	good	
yields.	Analogous	synthesis	using	compound	2c	with	hydrazine	
hydrate	 in	 the	 presence	 of	 glacial	 acetic	 acid	 could	 not	 be	
achieved,	 formation	 of	 a	 complex	 mixture	 of	 unidentified	
products	 was	 observed.	 Pyrazolines	 3b	 and	 3c	 were	
synthesized	by	Kok	et	al.	[40],	using	another	method	which	was	
reported	in	the	cited	reference.	For	the	synthesis	of	compound	
7‐(4‐fluorobenzylidene)‐3‐(4‐fluorophenyl)‐3,3a,4,5,6,7‐hexa	
hydro‐2H‐indazole	 (3b),	 we	 have	 used	 Claisen‐Schmidt	
condensation	[31‐39]	(Yield:	70%),	without	catalyst.	But	Kok	et	
al.	have	used	few	drops	of	acetic	acid	as	catalyst	(Yield:	72%).	
For	 the	 synthesis	 of	 compound	 1‐(7‐(4‐fluorobenzylidene)‐3‐
(4‐fluorophenyl)‐3,3a,4,5,6,7‐hexahydro‐2H‐indazol‐2‐yl)	
ethanone	 (3c),	 Kok	 et	 al.	 was	 used	 a	 method	 [40]	 which	
contains	 two	 steps:	 Step	 1,	 preparation	 of	 7‐(4‐fluoro	
benzylidene)‐3‐(4‐fluorophenyl)‐3,3a,4,5,6,7‐hexahydro‐2H‐
indazole	 (3b);	 Step	 2,	 Alkylation	 of	 compound	 3b,	 using	
pyridine	 as	 a	 solvent,	 and	 benzoyl	 chloride	 as	 reagent.	 As	
against	we	have	synthesized	compound	(3c)	in	a	single	step	by	
the	classical	1,3‐dipolar	cycloadditions	[1]	using	the	compound,	
6‐bis(4‐fluoro	 benzylidene)cyclohexanone	 (2b)	 as	 substrate,	
and	ethanol	 as	 solvent.	Compounds	3a	 and	3d	were	 two	new	
pyrazolines	 characterized	 by	 melting	 points,	 IR,	 1H	 and	 13C	
NMR	 spectra.	 The	 IR	 spectra	 showed	 a	 strong	 band	 for	 the	
(C=N)	 group	 at	 1595	 cm‐1	 and	 a	 band	 at	 1500	 cm‐1	 for	 C=C	
group.	In	the	spectra	1H	NMR,	the	olefinic	protons	gave	a	singlet	
signal	at	(5.95‐7.41	ppm).	13C	NMR	chemical	shifts	of	the	(C=N)	
group	have	been	assigned	at	(156.6‐156.7	ppm).		
	
	
4.	Conclusion		
	
In	 conclusion,	 we	 have	 synthesized	 a	 series	 of	 2‐
pyrazolines	 3a‐d	 by	 1,3‐dipolar	 cycloadditions	 using	 α,β‐
unsaturated	 cyclohexanone	 derivatives	 as	 starting	 materials.	
Pyrazolines	3a	 and	3c	are	very	 stable	 compounds,	 a	property	
which	 may	 render	 them	 especially	 useful	 substances	 in	 drug	
research.	Compounds	3b	and	3d	would	be	useful	as	synthetic	
precursors	for	preparing	various	pyrazoline	derivatives	due	to	
the	presence	of	reactive	group	(N‐H).	Bioactivities	studies	of	all	
synthesized	 compounds	 will	 be	 reported	 elsewhere	 in	 near	
future.		
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